Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study

INTRODUCTION: Binge eating disorder (BED) is associated with obesity and major depressive disorder (MDD). Naltrexone extended-release (ER)/bupropion ER (NB) is approved as an adjunct to diet and physical activity for chronic weight management. In a prospectively designed 24-week open-label, single-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerdjikova, Anna I., Walsh, Brandon, Shan, Kevin, Halseth, Amy E., Dunayevich, Eduardo, McElroy, Susan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656719/
https://www.ncbi.nlm.nih.gov/pubmed/28918581
http://dx.doi.org/10.1007/s12325-017-0613-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656719/
https://www.ncbi.nlm.nih.gov/pubmed/28918581
http://dx.doi.org/10.1007/s12325-017-0613-9

Ejemplares similares